- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 495/18 - Systèmes pontés
Détention brevets de la classe C07D 495/18
Brevets de cette classe: 48
Historique des publications depuis 10 ans
|
4
|
3
|
3
|
4
|
5
|
6
|
2
|
5
|
2
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Trustees of Columbia University in the City of New York | 3589 |
4 |
| Teijin Limited | 1256 |
4 |
| Fred Hutchinson Cancer Center | 451 |
4 |
| Mutabilis | 27 |
3 |
| University of Washington | 2349 |
3 |
| Sanofi | 4093 |
3 |
| Abbvie Inc. | 1801 |
2 |
| Oricula Therapeutics LLC | 2 |
2 |
| Rhode Island Board of Education, State of Rhode Island and Providence Plantations | 12 |
2 |
| Zomagen Biosciences Ltd | 15 |
2 |
| ExxonMobil Research And Engineering Company | 2562 |
1 |
| Abbott Laboratories | 2399 |
1 |
| FUJIFILM Corporation | 29586 |
1 |
| AbbVie Deutschland GmbH & Co. KG | 262 |
1 |
| JSR Corporation | 2530 |
1 |
| Duk San Neolux Co., Ltd. | 659 |
1 |
| Fred Hutchinson Cancer Research Center | 356 |
1 |
| Gilead Sciences, Inc. | 2049 |
1 |
| Icahn School of Medicine at Mount Sinai | 958 |
1 |
| Lixte Biotechnology, Inc. | 64 |
1 |
| Autres propriétaires | 9 |